Asset Details
Do you wish to reserve the book?
Avascular necrosis or rapid destruction of the hip following hip intra-articular corticosteroid injections: a systematic review
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Avascular necrosis or rapid destruction of the hip following hip intra-articular corticosteroid injections: a systematic review
Do you wish to request the book?
Avascular necrosis or rapid destruction of the hip following hip intra-articular corticosteroid injections: a systematic review
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Avascular necrosis or rapid destruction of the hip following hip intra-articular corticosteroid injections: a systematic review
2025
Overview
Purpose
This study aimed to systematically review the literature to identify the incidence of avascular necrosis (AVN) following hip intra-articular corticosteroid injections (IACSIs) as well as to elucidate risk factors that may predispose patients to AVN following IACSI.
Methods
The MEDLINE, Embase, PubMed, and Web of Science databases were systematically searched through inception to July 21, 2024, in accordance with the PRISMA statement with data extracted for descriptive analysis. The inclusion criteria were hip IACSI and AVN of the femoral head. AVN identified solely prior to IACSI, animal studies, in vitro studies, and studies on paediatric populations were excluded.
Results
A total of 3,652 studies were identified and screened resulting in a total of 14 studies that met the inclusion criteria. Seven were case reports, four were retrospective case-series, and three were retrospective cohort studies. The incidence of femoral head AVN following IACSI ranged from 0.6 to 20.4%. Kelly et al. reported that patient-related factors associated with increased rate of AVN included elevated BMI (
p
= 0.025), history of cancer therapy (
p
= 0.012), low serum Vitamin D (
p
= 0.030), and multiple injections (
p
= 0.004).
Conclusion
In the present literature, the incidence of AVN after hip IACSI ranges from 0.6 to 20.4% with mean follow-up times ranging from 5.4 to 25.3 months. Further randomized controlled trials are necessary to elucidate if there is a causative relationship between hip IACSI and AVN.
Publisher
Springer Berlin Heidelberg,Springer Nature B.V
